Bill > HR5630

This bill amends the Public Health Service Act to require states to provide more detailed information in their Substance Use Prevention, Treatment, and Recovery Services block grants. Specifically, states must now describe the types of medication-assisted treatment (MAT) drugs available in their care system, their programs and protocols for preventing diversion and misuse of these medications, data on medication misuse (including instances of mixing MAT drugs with other prescription drugs), and their drug screening protocols, particularly for patients receiving medication-assisted treatment. Medication-assisted treatment is a comprehensive approach to treating substance use disorders that combines FDA-approved medications with counseling and behavioral therapies. The bill aims to increase transparency and oversight of substance use treatment programs by requiring states to provide more comprehensive information about their MAT practices and potential challenges in implementing these treatments.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/5630/all-info